Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Short-term Investments (2021 - 2024)

Universe Pharmaceuticals (UPC) has disclosed Short-term Investments for 4 consecutive years, with $1.4 billion as the latest value for Q3 2024.

  • Quarterly Short-term Investments rose 100691.56% to $1.4 billion in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $1.4 billion through Sep 2024, up 100691.56% year-over-year, with the annual reading at $1.4 billion for FY2024, 100691.56% up from the prior year.
  • Short-term Investments hit $1.4 billion in Q3 2024 for Universe Pharmaceuticals, up from $1.4 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $1.4 billion in Q3 2024 to a low of $1.4 million in Q3 2023.
  • Historically, Short-term Investments has averaged $351.5 million across 4 years, with a median of $13.4 million in 2021.
  • Biggest five-year swings in Short-term Investments: tumbled 89.6% in 2023 and later skyrocketed 100691.56% in 2024.
  • Year by year, Short-term Investments stood at $13.7 million in 2021, then fell by 4.2% to $13.1 million in 2022, then crashed by 89.6% to $1.4 million in 2023, then surged by 100691.56% to $1.4 billion in 2024.
  • Business Quant data shows Short-term Investments for UPC at $1.4 billion in Q3 2024, $1.4 million in Q3 2023, and $13.1 million in Q3 2022.